
DoD Is The Largest Investor In Only American Rare Earth Mineral Mine
Under the 1933 Buy American Act and the 1941 Berry Amendment, the United States military is generally required to buy American-made products. The laws further prioritize domestic sourcing for goods, and that products for military use contain a certain percentage of U.S. components and materials.
Where that has been a problem is in the increasingly reliance on components that require rare earth minerals, which the United States has a limited supply of, while upwards of 70% are imported from China. To help address the issue, the U.S. Department of Defense announced last week that it had acquired a 15% stake in the MP Materials mine, becoming the company's largest shareholder.
MP Materials, the operator of the only American rare earths mine, received a $400 million investment from the Pentagon, which will help fund the processing capabilities at its Mount Pass, California, facility and enable the construction of a second magnet manufacturing plant.
"It's strategically important for the Pentagon to ensure that its Tier 1 industrial base has access to U.S.-sourced rare earth metals and magnets," explained David Argyle, CEO of REalloys Inc., a company focused on the production of rare earth elements and high-performance magnet materials.
"The MP DoD transaction provides a very healthy base load of supply to meet demand," Argyle added, but acknowledged that additional US sources need to be available commencing in 2026, 2027, and beyond.
Greater Investment Is Needed
There has already been speculation that President Donald Trump could use emergency powers to allow the United States to gain greater control over domestic industries and resources. The Defense Production Act, a Cold War-era law that grants the president significant emergency authority to control domestic industries, was invoked by Trump during his first term and by former President Joe Biden during the pandemic.
However, investments are also needed, suggested Brandon Daniels, CEO of AI supply chain company Exiger.
"Critical minerals are the lifeblood of our defense capabilities. Everything from specialized engine components for high heat environments to navigation systems demands rare earth minerals at the beginning of the supply chain," said Daniels. "It's a national security imperative that the defense department use its resources to create sustainable independent streams of these resources."
The $400 million investment shouldn't be seen as too little or too late.
"The Pentagon is doing this because it's not always economically viable to invest the capital expenditure at the beginning of the process, and the U.S. ought to accelerate its access to these minerals," added Daniels.
Such strategic investment in rare earths and critical minerals is a crucial step in securing our domestic supply chain and enhancing national security. Still, it is just part of the solution.
"The defense industry depends on these strategic materials for everything from weaponry, base operations, to communications and other additional technologies," noted David Klanecky, CEO of lithium battery recycling firm Cirba Solutions. "Investment by the Department of Defense demonstrates a prioritization of this key market, brings urgency to the sector, and underscores the importance of developing a reliable supply at home rather than depending on raw material imports from foreign entities of concern."
Waste Not, Want Not
Without stable access to rare earths and critical minerals, our national security is at significant risk. To this end, the U.S. military needs to be far less disposable. As with consumer products that end up in landfills, a vast amount of valuable materials is never harvested and reused.
"It is also important to look at the supply chain holistically and invest in all domestic manufacturing," Klanecky added. "For example, battery recycling can significantly boost domestic production and refinement of critical minerals, and it is one of the most immediate and scalable ways to secure supply and keep valuable materials in circulation in the U.S. long after they've been extracted."
More Efforts Need To Be Made
The $400 million investment by the Pentagon should be viewed as a positive first step, but it is far from resolving a problem that has been decades in the making.
"The one mining project won't be enough to fulfill all demand for all rare earths that are used in advanced technologies," warned Daniels.
"But it is a big step in the right direction," Daniels continued. "Between this type of mining and the advancements in recycling, we can achieve independence for many of our most critical rare earths. For instance, with coal ash leaching in the United States, we could generate enough germanium to supply all of our Semiconductor, Photovoltaic, and Fiber Optic cable needs."
The growing need for rare earths is just one of several problems that the Pentagon faces, along with manufacturing supply chain challenges, an aging workforce at America's shipyards, and cost overruns on nearly all its programs. However, the demand for rare earths needs to be taken as seriously as the other issues, yet there is no easy solution.
"Rare earth and critical minerals are essential to powering today's modern and digital world. Meeting the growing demand for these materials will require a comprehensive strategy that includes investment, partnerships, and an overall diversified approach across extraction, refinement, and recycling," said Klanecky. "Taking this holistic view of the supply chain is necessary if the U.S. wants a long-term solution to creating a stable domestic supply and enabling the country to achieve national security goals."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Federal cuts leave Los Angeles County health system in crisis
Los Angeles County's health system, which is responsible for the care of the region's poorest, is careening toward a financial crisis because of cuts from a presidential administration and Republican-led Congress looking to drastically slash the size of government. President Trump's "Big Beautiful Bill," which passed earlier this month, is expected to soon claw $750 million per year from the county Department of Health Services, which oversees four public hospitals and roughly two dozen clinics. In an all-staff email Friday, the agency called the bill a "big, devastating blow to our health system" and said a hiring freeze had gone into effect, immediately. And the Trump administration's budget for the next fiscal year will likely result in a $200-million cut to the county Department of Public Health, whose responsibilities include monitoring disease outbreaks, inspecting food and providing substance use treatment. 'I'm not going to sugarcoat it. I'm not going to say we survive this,' said Barbara Ferrer, head of the public health department, in an interview. 'We can't survive this big a cut.' Both Ferrer and Department of Health Services head Christina Ghaly warned that the federal cuts will devastate their agencies — and the patients they serve — for years to come. Employee layoffs are likely. In April, the White House announced it was ending infectious disease grants worth billions of dollars, including $45 million that L.A. County was supposed to use to combat the spread of measles and bird flu. California has joined other states in a lawsuit fighting the cuts, and the court has issued a preliminary injunction suspending the cuts. This month, the county public health department lost another $16 million after Trump's bill cut funding for a program educating food stamp recipients about how to buy healthy meals. And there's more to come. The Trump administration's proposed budget for 2026 will be the biggest blow yet, Ferrer warned, yanking $200 million from her department — a 12% cut. 'I'm old. I've been around for a long time,' said Ferrer, whose work in public health dates back to the Reagan administration. 'I've never actually seen this much disdain for public health." Ferrer said the cuts mean she no longer has enough money for the county's bioterrorism watch program, which monitors for outbreaks that might signal a biological attack. Soon, she said, county officials may have to stop testing ocean water for toxins year round, cutting back to just half the year. 'Like, you want to swim? You want to know that the water is safe where you swim, then oppose these kinds of cuts,' she said. "That affects everybody who goes to the beach." Layoffs are likely, said Ferrer. About 1,500 public health staffers are supported through federal grants. More than half the federal money the department receives is funneled to outside organizations, which would likely need to make cuts to stay afloat. A similarly grim cost analysis is underway at the county Department of Health Services, where executives said they expect to lose $280 million this fiscal year because of the bill. 'I can't make a promise that we will be able to avoid layoffs because of the magnitude of the challenges,' said Ghaly. Ghaly said the bill slashed the extra Medicaid money the county typically gets to cover care for low-income patients. They expect many patients might be kicked off Medicaid because of new eligibility and work requirements. The federal government is pulling back on payments for emergency services for undocumented people, meaning the county will have to foot more of the bill. The White House did not respond to a request for comment. Read more: Trump's 'big, beautiful' megabill wins final approval after marathon overnight session Department of Health Services officials said they expect to lose $750 million per year by 2028. By then, the agency's budget deficit is projected to have ballooned to $1.85 billion. In an attempt to pump more cash into the system, L.A. County supervisors voted on Tuesday to increase a parcel tax first approved by voters in 2002, which is expected to raise an additional $87 million for the county's trauma care network. After a long debate Tuesday, Supervisors Holly Mitchell and Lindsey Horvath worked to direct $9 million of the parcel tax money to Martin Luther King Jr. Community Hospital, a private hospital that serves as a critical safety net for South Los Angeles residents who would otherwise find themselves in a medical desert. Without that cash infusion from the county, the cuts in Trump's bill would have put the hospital at risk of closing, since the majority of patients in its emergency room are on Medicaid, said Elaine Batchlor, Martin Luther King's chief executive officer. 'If they've lost their Medicaid coverage, we simply won't get paid for those patients,' she said. Martin Luther King replaced a county hospital that closed after losing national accreditation in 2005 because of serious medical malpractice, landing it the nickname 'Killer King." 'The fact that that hospital closed in the first place I think is criminal, and I intend to do all I can to protect the integrity of the services,' said Mitchell, whose district includes the hospital and who pushed for it to get a cut of money from the parcel tax increase. Local health providers said that changes at the state level have created additional uncertainty. The state budget for this fiscal year freezes enrollment in Medi-Cal, California's version of Medicaid, for undocumented immigrants ages 19 and older starting in January. Medi-Cal recipients ages 19 to 59 will have to pay a $30 monthly premium beginning July 1, 2027. "Most families [we serve] are making about $2,400 to $2,600 a month. They're going to have to choose between paying their Medi-Cal fees for a family of four — that's $120 a month — or paying rent or paying for food," said Jim Mangia, head of St. John's Community Health, who said the cuts will disrupt care for tens of thousands of low-income residents. Read more: California, other states sue Trump administration over cuts to CDC infectious-disease funding The St. John's clinic, which gets most of its revenue from Medi-Cal reimbursements, serves more than 120,000 patients a year, most of whom live below the federal poverty line. If the clinic doesn't find a way to replace the lost revenue, Mangia warned, services will have to be reduced. The clinic recently started treating immigrant patients in their homes after realizing they had been skipping appointments because they feared being arrested by federal immigration agents. 'Then what we're looking at is closing several health centers,' said Mangia. 'We're looking at laying off hundreds of staff." At Venice Family Clinic, a community health center that serves nearly 45,000 patients annually, 80% of patients rely on Medi-Cal. Roughly half the clinic's revenue comes from Medi-Cal reimbursements. Dr. Mitesh Popat, a family physician and head of the clinic, said that federal policy changes — especially more frequent paperwork and added work requirements — will likely push eligible patients off of Medi-Cal. He said the clinic is exploring ways to expand support for patients to navigate the paperwork and keep their coverage. "This puts a bunch of barriers in the way of people who already have enough challenges in life," Popat said. "They're trying to make it, trying to survive, trying to put food on the table." Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week. This story originally appeared in Los Angeles Times. Solve the daily Crossword
Yahoo
38 minutes ago
- Yahoo
Which Is the Best "Magnificent Seven" Stock to Buy Right Now?
Key Points This dominant internet enterprise is already positioned as a leader in the AI race, with popular products and services, a cloud platform, and chips. There are few companies that have the financial firepower that this one does, letting it always operate from a position of strength. Despite being a high-quality business, shares trade at a below-market valuation multiple. 10 stocks we like better than Alphabet › Before, it was the FAANG stocks. In recent years, the term "Magnificent Seven" was used to group what the market believes are some of most dominant businesses on Earth. These companies' shares soared, a key factor putting them in investors' good graces. But among these elite businesses, which one is the best Magnificent Seven stock that investors should buy right now? The answer is as clear as day. Dominant internet enterprise operating from a position of strength The Magnificent Seven stock that investors should buy today is Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG). As artificial intelligence (AI) alters how people search for and obtain information, there have been real worries that this internet giant's competitive position is under attack. However, I don't think investors should worry. Google Search is Alphabet's bread and butter, raking in $50.7 billion in revenue in the first quarter. That figure was up 9.7% year over year and 25.5% higher than exactly two years ago despite the rise of OpenAI's ChatGPT. CEO Sundar Pichai says that the AI Overviews feature is "going very well with over 1.5 billion users per month." Alphabet operates from a position of power because it has "15 products that each serve half a billion people, and six that serve over 2 billion each," according to Pichai. No company has this type of reach and broad adoption, giving Alphabet a unique advantage with its distribution capabilities to introduce new AI features. And for what it's worth, Google Gemini is already integrated into these offerings. Alphabet is in a position to be a leading AI company, at least when it comes to serving individual users out there. However, the business is also poised to be an AI powerhouse from an enterprise perspective thanks to Google Cloud. Specifically, the Vertex AI platform lets customers build and deploy their own Generative AI applications. This invaluable offering looks to be a mission-critical partner for customers that don't want to get left behind in the AI race. Besides Google Cloud making Alphabet a major player at the AI platform layer, the company is also working on infrastructure. Alphabet is developing tensor processing units (TPUs), its custom-built chips made to handle inference at a larger scale. "It delivers more than 10 (times) improvement in compute power over our recent high-performance TPU, while being nearly twice as power efficient," Pichai claimed on the Q1 2025 earnings call. With deep pockets ($95 billion in cash, cash equivalents, and marketable securities as of March 31), Alphabet has what it takes to play offense and keep its foot on the gas pedal. The company plans to spend a whopping $75 billion in capital expenditures this year to buttress its technological infrastructure and build servers and data centers. We haven't even mentioned YouTube yet, which might get overshadowed by the market's focus on AI. According to data from Nielsen, YouTube commands the most daily TV viewing time in the U.S. among any streaming rival, well ahead of Netflix. This video platform also benefits from a powerful network effect, with the service becoming more valuable as the number of content creators and viewers grows. Bargain hiding in plain sight It's reasonable for investors to think that the best opportunities come from smaller companies whose stocks fly under the radar. This just isn't the case, though. Alphabet is the perfect example of a bargain that's hiding in plain sight. Yes, it carries a massive $2.2 trillion market cap. And it did bring in $350 billion in revenue in 2024. However, its valuation is compelling. As of July 15, the stock trades at a price-to-earnings (P/E) ratio of just 20.3. This represents a discount to the overall S&P 500. And it makes Alphabet the cheapest stock of all the Magnificent Seven businesses, supporting the argument that this company should be in your portfolio. Should you buy stock in Alphabet right now? Before you buy stock in Alphabet, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Alphabet wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $687,149!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,060,406!* Now, it's worth noting Stock Advisor's total average return is 1,069% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 15, 2025 Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Neil Patel has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet and Netflix. The Motley Fool has a disclosure policy. Which Is the Best "Magnificent Seven" Stock to Buy Right Now? was originally published by The Motley Fool Sign in to access your portfolio


Associated Press
an hour ago
- Associated Press
AAPL SECURITIES NEWS: Did Apple Inc. (NASDAQ:AAPL) Commit Securities Fraud? Contact BFA Law by August 19 Class Action Deadline
NEW YORK, July 20, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Apple Inc. (NASDAQ: AAPL) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Apple, you are encouraged to obtain additional information by visiting: Investors have until August 19, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Apple securities. The case is pending in the U.S. District Court for the Northern District of California and is captioned Tucker v. Apple Inc., et al., No. 5:25-cv-05197. Why was Apple Sued for Securities Fraud? Apple is a multinational technology company that engages primarily in the businesses of smart-devices and artificial intelligence ('AI'). Apple's software includes a digital personal assistant called 'Siri,' which was first introduced in October 2011. The complaint alleges that Apple misrepresented Siri's advanced AI-based features as well as its ability to deliver them within the iPhone 16 product cycle. In truth, as alleged, Apple lacked a functional prototype of Siri's purported advanced AI-based features and misrepresented the time it would take to integrate such features into its devices. The Stock Declines as the Truth is Revealed On March 7, 2025, Apple announced it was indefinitely delaying several AI-based Siri features, citing development delays and pushing their release to sometime 'in the coming year.' On this news, the price of Apple stock declined $11.59 per share, or almost 5%, from $239.07 per share on March 7, 2025, to $227.48 per share on March 10, 2025, the following trading day. Then, on June 9, 2025, Apple hosted its Worldwide Developer Conference for 2025. Noticeably, Apple failed to announce any new updates regarding advanced Siri features. Analysts and media outlets described the WWDC as 'underwhelming' and 'disappointing,' with CNN stating that 'it's unlikely that any of the announcements made at Monday's event will change the perception that Apple is behind its competitors in AI.' On this news, the price of Apple stock declined $2.47 per share, or over 1%, from $203.92 on June 6, 2025, to $201.45 per share on June 9, 2025, the following trading day. Click here for more information: What Can You Do? If you invested in Apple you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Submit your information by visiting: Or contact: Ross Shikowitz [email protected] 212-789-3619 Why Bleichmar Fonti & Auld LLP? BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named 'Elite Trial Lawyers' by the National Law Journal, among the top '500 Leading Plaintiff Financial Lawyers' by Lawdragon, 'Titans of the Plaintiffs' Bar' by Law360 and 'SuperLawyers' by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd. For more information about BFA and its attorneys, please visit Attorney advertising. Past results do not guarantee future outcomes.